secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2023-03-14T23:59:59+00:00
Accession:  0001779128-23-000025
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blade Q4 revenue $38.1M (+55% YoY); FY revenue $146.1M (+118%)
--------------------------------------------------------------

- Q4 revenue $38.1M, up 55% YoY; FY revenue $146.1M, up 118% YoY.
- Short Distance revenue up 51% in Q4; MediMobility Organ Transport revenue up 120% in Q4.
- Flight Profit increased 38% in Q4, driven by organic and inorganic growth.
- Completed first piloted EVA test flight in NYC with BETA Technologies.
- Management expects cash balance available for acquisitions; path to profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000177912823000025/0001779128-23-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000177912823000025/blde-20230314.htm
  HTML page:      https://secwatch.observer/filing/0001779128-23-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer